MXPA05013220A - Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2. - Google Patents
Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2.Info
- Publication number
- MXPA05013220A MXPA05013220A MXPA05013220A MXPA05013220A MXPA05013220A MX PA05013220 A MXPA05013220 A MX PA05013220A MX PA05013220 A MXPA05013220 A MX PA05013220A MX PA05013220 A MXPA05013220 A MX PA05013220A MX PA05013220 A MXPA05013220 A MX PA05013220A
- Authority
- MX
- Mexico
- Prior art keywords
- diabetes mellitus
- treating diabetes
- mellitus type
- combined
- pharmaceutical compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/64—Sulfonylureas, e.g. glibenclamide, tolbutamide, chlorpropamide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Endocrinology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
La presente invencion describe una composicion farmaceutica que comprende una combinacion de sustancias antidiabeticas como una sulfonilurea como lo es la Glimepirida y una tiazolidinediona como lo es la Pioglitazona para el uso farmacologico de la composicion en el tratamiento de la Diabetes Mellitus tipo 2; la composicion produce un producto de combinacion con propiedades mejoradas y produce un efecto sinergico. En resumen es una composicion farmaceutica sinergica que comprende una combinacion sinergica de una sulfonilurea y una tiazolidinediona para el tratamiento de la Diabetes Mellitus tipo 2, en la cual la sulfonilurea es la Glimepirida y/o cualquier de sus sales y la Tiazolidinediona es la Pioglitazona y/o cualquier de sus sales.
Priority Applications (6)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA05013220A MXPA05013220A (es) | 2005-12-06 | 2005-12-06 | Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2. |
| BRPI0619616-0A BRPI0619616A2 (pt) | 2005-12-06 | 2006-06-23 | composições farmacêuticas que compreendem substáncias antidiabéticas combinadas para seu uso em diabetes mellitus tipo 2 |
| PCT/MX2006/000060 WO2007067027A1 (es) | 2005-12-06 | 2006-06-23 | Composiciones farmacéuticas que comprenden sustancias anti diabéticas combinadas para su uso en diabetes mellitus tipo 2 |
| EP06769371A EP1958636A1 (en) | 2005-12-06 | 2006-06-23 | Pharmaceutical compositions containing combined antidiabetic substances for use in type 2 diabetes mellitus |
| EC2008008507A ECSP088507A (es) | 2005-12-06 | 2008-06-06 | Composiciones farmacéuticas que comprenden sustancias antidiabéticas combinadas para su uso en diabetes mellitus tipo 2 |
| CR10053A CR10053A (es) | 2005-12-06 | 2008-06-06 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MXPA05013220A MXPA05013220A (es) | 2005-12-06 | 2005-12-06 | Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MXPA05013220A true MXPA05013220A (es) | 2007-06-05 |
Family
ID=38123117
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MXPA05013220A MXPA05013220A (es) | 2005-12-06 | 2005-12-06 | Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2. |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1958636A1 (es) |
| BR (1) | BRPI0619616A2 (es) |
| CR (1) | CR10053A (es) |
| EC (1) | ECSP088507A (es) |
| MX (1) | MXPA05013220A (es) |
| WO (1) | WO2007067027A1 (es) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI238064B (en) * | 1995-06-20 | 2005-08-21 | Takeda Chemical Industries Ltd | A pharmaceutical composition for prophylaxis and treatment of diabetes |
| US5859037A (en) * | 1997-02-19 | 1999-01-12 | Warner-Lambert Company | Sulfonylurea-glitazone combinations for diabetes |
| US20040147564A1 (en) * | 2003-01-29 | 2004-07-29 | Rao Vinay U. | Combinations of glimepiride and the thiazolidinedione for treatment of diabetes |
| US7700128B2 (en) * | 2003-10-31 | 2010-04-20 | Takeda Pharmaceutical Company Limited | Solid preparation comprising an insulin sensitizer, an insulin secretagogue and a polyoxyethylene sorbitan fatty acid ester |
-
2005
- 2005-12-06 MX MXPA05013220A patent/MXPA05013220A/es not_active Application Discontinuation
-
2006
- 2006-06-23 BR BRPI0619616-0A patent/BRPI0619616A2/pt not_active Application Discontinuation
- 2006-06-23 WO PCT/MX2006/000060 patent/WO2007067027A1/es not_active Ceased
- 2006-06-23 EP EP06769371A patent/EP1958636A1/en not_active Withdrawn
-
2008
- 2008-06-06 CR CR10053A patent/CR10053A/xx not_active Application Discontinuation
- 2008-06-06 EC EC2008008507A patent/ECSP088507A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| BRPI0619616A2 (pt) | 2011-10-04 |
| ECSP088507A (es) | 2008-07-30 |
| WO2007067027A1 (es) | 2007-06-14 |
| CR10053A (es) | 2008-08-06 |
| EP1958636A1 (en) | 2008-08-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2007111864A3 (en) | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | |
| WO2007064931A3 (en) | Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis | |
| WO2007136577A3 (en) | Glucagon receptor antagonist compounds, compositions containing such compounds and methods of use | |
| CL2006003672A1 (es) | Compuestos derivados de pirimido-[4,5-b]-oxazinas; procedimiento de preparacion; composicion farmaceutica que comprende a dicho compuesto; y uso del compuesto en el tratamiento de diabetes mellitus y/u obesidad. | |
| UA96308C2 (ru) | Антагонисты рецептора глюкагона, композиция, которая содержит такие соединения, и их применение | |
| BRPI0619153A8 (pt) | derivados de 4-aminopirroltriazina substituída, e composição farmacêutica | |
| WO2009137391A3 (en) | Benzene sulfonamide thiazole and oxazole compounds | |
| MX2009003741A (es) | Composiciones liquidas de calcogenuro y metodos para fabricar y utilizar las mismas. | |
| PL1965798T3 (pl) | Użyteczne antybiotyki monobaktamowe | |
| IL196543A (en) | Pyridazinone derivatives, pharmaceutical preparations containing them for use in the treatment of disorders | |
| WO2007082808A3 (en) | Thiazoles as 11 beta-hsd1 inhibitors | |
| CL2007001006A1 (es) | Compuestos derivados de piperidina u 8-aza-biciclo[3.2.1]octano sustituidos; formulacion farmaceutica; producto; y uso para el tratamiento o prevencion de enfermedades tales como diabetes mellitus no insulino dependiente, artritis, obesidad, dislipid | |
| ZA200802454B (en) | Use of thienopyridone derivatives as AMPK activators and pharmaceutical compositions containing them | |
| MY182720A (en) | Pharmaceutical compositions | |
| WO2008013840A3 (en) | Erastin analogs and uses thereof | |
| JO2578B1 (en) | Compounds Theophene benzimidazole | |
| TW200722100A (en) | A therapeutic agent for a β related disorders | |
| TW200732296A (en) | Novel compounds | |
| CL2007001530A1 (es) | Compuestos derivados de tiazol, inhibidores de fbpasa; proceso de preparacion; composicion farmaceutica; y uso para el tratamiento y/o profilaxis de diabetes mellitus tipo i, ii y iii, desequilibrio de glucosa en ayunas, desequilibrio en la tolerancia de la glucosa y complicaciones de la diabetes. | |
| WO2007017145A3 (en) | Gsk-3 inhibitors | |
| WO2006116148A3 (en) | (7-arlysubstituted 2, 3-dihydr0-1-benz0furan-2-yl) alkylamines in the treatment' of substance abuse | |
| WO2005039626A3 (en) | Use of hydroxylated amino acids for treating diabetes | |
| TW200800993A (en) | Organic compounds | |
| MXPA05013220A (es) | Composiciones farmaceuticas que comprenden sustancias antidiabeticas combinadas para su uso en diabetes mellitus tipo 2. | |
| WO2007006521A3 (en) | Nutritional mixtures with a high and increased efficacy |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| GB | Transfer or assignment |
Owner name: WORLD-TRADE IMPORT-EXPORT, WTIE, AG.* |
|
| FA | Abandonment or withdrawal |